264
Views
8
CrossRef citations to date
0
Altmetric
Biomarkers

Comparison of serum eosinophil-derived neurotoxin levels between wheezing and non-wheezing groups in children with respiratory tract infection

, , PhD, , MD, , PhD, , MD, , MS, , MD & , MD, PhD show all
Pages 1211-1215 | Received 25 Nov 2018, Accepted 07 Jul 2019, Published online: 20 Aug 2019

References

  • Watt AP, Schock BC, Ennis M. Neutrophils and eosinophils: clinical implications of their appearance, presence and disappearance in asthma and COPD. Curr Drug Targets Inflamm Allergy 2005;4:415–423. doi: 10.2174/1568010054526313.
  • Holgate ST. Pathogenesis of asthma. Clin Exp Allergy 2008;38:872–897. doi: 10.1111/j.1365-2222.2008.02971.x.
  • Macdowell AL, Peters SP. Neutrophils in asthma. Curr Allergy Asthma Rep 2007;7:464–468.
  • Rosenberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 2007;119:1303–1310. doi: 10.1016/j.jaci.2007.03.048.
  • Moqbel R. Eosinophil-derived cytokines in allergic inflammation and asthma. Ann N Y Acad Sci 1996;796:209–217. doi: 10.1111/j.1749-6632.1996.tb32583.x.
  • Wolthers OD. Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma. Pediatr Allergy Immunol 2003;14:248–254. doi: 10.1034/j.1399-3038.2003.00030.x.
  • Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008;38:709–750. doi: 10.1111/j.1365-2222.2008.02958.x.
  • Kim CK. Eosinophil-derived neurotoxin: a novel biomarker for diagnosis and monitoring of asthma. Korean J Pediatr 2013;56:8–12. doi: 10.3345/kjp.2013.56.1.8.
  • Venge P. Monitoring the allergic inflammation. Allergy 2004;59:26–32.
  • Kim CK, Callaway Z, Fletcher R, Koh YY. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity. J Asthma 2010;47:568–573. doi: 10.3109/02770901003792833.
  • Kim CK, Callaway Z, Park JS, Kwon E. Utility of serum eosinophil-derived neurotoxin (EDN) measurement by ELISA in young children with asthma. Allergol Int 2017;66:70–74. doi: 10.1016/j.alit.2016.05.008.
  • Kim C-K, Choi J, Kim HB, Callaway Z, Shin BM, Kim J-T, Fujisawa T, Koh YY. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation. J Pediatr 2010;156:749–754. doi: 10.1016/j.jpeds.2009.12.001.
  • Gon Y, Ito R, Hattori T, Hiranuma H, Kumasawa F, Kozu Y, Endo D, Koyama D, Shintani Y, Eriko T, et al. Serum eosinophil-derived neurotoxin: correlation with persistent airflow limitation in adults with house-dust mite allergic asthma. Allergy Asthma Proc 2015;36:113–120. doi: 10.2500/aap.2015.36.3884.
  • Badar A, Hussain MM, Saeed W, Aslam M. Correlation of eosinophil derived neurotoxin with airway resistance in asthmatics. J Pak Med Assoc 2010;60:97–101.
  • Possa SS, Leick EA, Prado CM, Martins MA, Tiberio IF. Eosinophilic inflammation in allergic asthma. Front Pharmacol 2013;4:46.
  • Venge P, Byström J, Carlson M, Hâkansson L, Karawacjzyk M, Peterson C, Sevéus L, Trulson A. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999;29:1172–1186.
  • Boulet LP, FitzGerald JM, Reddel HK. The revised 2014 GINA strategy report: opportunities for change. Curr Opin Pulm Med 2015;21:1–7. doi: 10.1097/MCP.0000000000000125.
  • Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157:4–9. doi: 10.1164/ajrccm.157.1.9703002.
  • Bayes HK, Cowan DC. Biomarkers and asthma management: an update. Curr Opin Allergy Clin Immunol 2016;16:210–217. doi: 10.1097/ACI.0000000000000263.
  • Shaker M. New insights into the allergic march. Curr Opin Pediatr 2014;26:516–520. doi: 10.1097/MOP.0000000000000120.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.